Načítá se...
Lymph Node Status in Breast Cancer Does Not Predict Tumor Biology
BACKGROUND/OBJECTIVE. The 21-gene Oncotype DX® Breast Recurrence Score® (RS) assay has been prospectively validated as prognostic and predictive in node-negative estrogen receptor-positive (ER+)/HER2-breast cancer patients. Less is known about its prognostic role in node-positive breast cancer. We c...
Uloženo v:
| Vydáno v: | Ann Surg Oncol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6123264/ https://ncbi.nlm.nih.gov/pubmed/29968028 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-018-6598-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|